Our Publications

Dr. Ketan Patel has published over 110 Research Papers in international journals with over 2800 citations and H-Index of 35.

For updates, please visit:

https://scholar.google.com/citations?user=UK3F1XcAAAAJ&hl=en

https://www.linkedin.com/in/ketan-patel-58972755

M Vats, D Rathod, H Patel, T Richards, K Patel

Journal of Molecular Liquids 426, 127161

Self-emulsifying nano-PND oral delivery systems of PND1186: In silico modeling for bioavailability estimation

A Mir, T Acosta, M Concheiro-Guisan, SM Yellon, K Patel, SE Reznik

Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 167822

Improving the safety of N, N-dimethylacetamide (DMA) as a potential treatment for preterm birth in a pregnant mouse model using a vaginal nanoformulation

A Mir, T Acosta, M Concheiro-Guisan, SM Yellon, K Patel, SE Reznik

Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 167822

Improving the safety of N, N-dimethylacetamide (DMA) as a potential treatment for preterm birth in a pregnant mouse model using a vaginal nanoformulation

A Patel, A Saraswat, H Patel, ZS Chen, K Patel

CANCERS 17 (1)

Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer (vol 15,182, 2023)

Y Guo, HJ Patel, AS Patel, E Squillante, K Patel

Colloids and Surfaces B: Biointerfaces 245, 114320

Albendazole nanosuspension coated granules for the rapid localized release and treatment of colorectal cancer

S Palekar, PK Nukala, R Vartak, K Patel

International Journal of Pharmaceutics 590, 119944

Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse

R Vartak, M Patki, S Menon, J Jablonski, S Mediouni, Y Fu, ST Valente, B Billack, K Patel

International Journal of Pharmaceutics 589, 119863

β-cyclodextrin polymer/Soluplus® encapsulated Ebselen ternary complex (EβpolySol) as a potential therapy for vaginal candidiasis and pre-exposure prophylactic for HIV

Y Fu, D Rathod, K Patel

Experimental cell research 396 (1), 112275

Protein kinase C inhibitor anchored BRD4 PROTAC PEGylated nanoliposomes for the treatment of vemurafenib-resistant melanoma

M Patki, R Vartak, J Jablonski, S Mediouni, T Gandhi, Y Fu, E Cetindag, R Dave, ST Valente, K Patel

Colloids and Surfaces B: Biointerfaces 194, 111174

Efavirenz nanomicelles loaded vaginal film (EZ film) for preexposure prophylaxis (PrEP) of HIV

A Saraswat, M Patki, Y Fu, S Barot, VV Dukhande, K Patel

Nanomedicine 15 (18), 1761-1777

Nanoformulation of PROteolysis Targeting Chimera TArgeting ‘Undruggable’ C-Myc for The Treatment of Pancreatic Cancer

S Pujari, A Patel, S Gaikwad, K Patel, D Dabhade, A Chitalikar, K Joshi, V Bele

Journal of Antimicrobial Chemotherapy 75 (7), 1950-1954

Effectiveness of dolutegravir-based antiretroviral treatment for HIV-2 infection: retrospective observational study from Western India

R Vartak, S Menon, M Patki, B Billack, K Patel

European Journal of Pharmaceutical Sciences 148, 105323

Ebselen nanoemulgel for the treatment of topical fungal infection

ZX Wu, Z Peng, Y Yang, JQ Wang, QX Teng, ZN Lei, YG Fu, K Patel, L Liu, L Lin, C Zou, ZS Chen

Frontiers in Oncology 10, 674

M3814, a DNA-PK inhibitor, modulates ABCG2-mediated multidrug resistance in lung cancer cells

S Menon, R Vartak, K Patel, B Billack

Nanomedicine: Nanotechnology, Biology and Medicine 37, 102428

Evaluation of the antifungal activity of an ebselen-loaded nanoemulsion in a mouse model of vulvovaginal candidiasis

M Patki, A Saraswat, S Bhutkar, V Dukhande, K Patel

Experimental cell research 405 (2), 112660

In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells

Y Fu, A Saraswat, Z Wei, MY Agrawal, VV Dukhande, SE Reznik, K Patel

Pharmaceutics 13 (7), 1005

Development of dual ARV-825 and nintedanib-loaded PEGylated nano-liposomes for synergistic efficacy in vemurafnib-resistant melanoma

HP Vemana, A Saraswat, S Bhutkar, K Patel, VV Dukhande

Nanomedicine 16 (13), 1081-1095

A Novel Gene Therapy for Neurodegenerative Lafora Disease Via Epm2A-Loaded Dlindma Lipoplexes

R Vartak, SM Patil, A Saraswat, M Patki, NK Kunda, K Patel

Nanomedicine 16 (14), 1187-1202

Aerosolized Nanoliposomal Carrier of Remdesivir: An Effective Alternative for COVID-19 Treatment In Vitro

A Bagde, N Patel, K Patel, E Nottingham, M Singh

Drug delivery and translational research 11, 1156-1165

Sustained release dosage form of noscapine HCl using hot melt extrusion (HME) technique: Formulation and pharmacokinetics

HP Vemana, A Saraswat, S Bhutkar, K Patel, V Dukhande

The FASEB Journal 35

Designing of DLinDMA‐Anchored Liposomal Carrier for Gene Therapy of Rare Genetic Lafora Disease

S Menon, X Liang, R Vartak, K Patel, A Di Stefano, I Cacciatore, L Marinelli, B Billack

Pharmaceutics 13 (5), 633

Antifungal Activity of Novel Formulations Based on Terpenoid Prodrugs against C. albicans in a Mouse Model

M Patki, S Palekar, S Reznik, K Patel

International Journal of Pharmaceutics 597, 120329

Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment

HK Mamidi, S Palekar, PK Nukala, SM Mishra, M Patki, Y Fu, P Supner, G Chauhan, K Patel

International Journal of Pharmaceutics 593, 120101

Process optimization of twin-screw melt granulation of fenofibrate using design of experiment (DoE)

ZX Wu, Y Yang, JQ Wang, WM Zhou, J Chen, YG Fu, K Patel, ZS Chen, JY Zhang

Frontiers in pharmacology 11, 615824

Elevated ABCB1 expression confers acquired resistance to aurora kinase inhibitor GSK-1070916 in cancer cells

M Patki, S Palekar, PK Nukala, R Vartak, K Patel

Aaps Pharmscitech 22, 1-12

Overdose and alcohol sensitive immediate release system (OASIS) for deterring accidental overdose or abuse of drugs

A Patel, A Saraswat, H Patel, ZS Chen, K Patel

Cancers 17 (1), 44

Correction: Patel et al. Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer.

R Vartak, K Patel

Journal of Controlled Release 376, 502-517

Targeted nanoliposomes of oncogenic protein degraders: Significant inhibition of tumor in lung-cancer bearing mice

H Patel, A Patel, M Vats, K Patel

AAPS PharmSciTech 25 (8), 271

Albumin and Polysorbate-80 Coated Sterile Nanosuspensions of Mebendazole for Glioblastoma Therapy

A Saraswat, HP Vemana, V Dukhande, K Patel

Molecular Therapy-Nucleic Acids 35 (3)

Novel gene therapy for drug-resistant melanoma: Synergistic combination of PTEN plasmid and BRD4 PROTAC-loaded lipid nanocarriers

S Bhutkar, A Yadav, H Patel, S Barot, K Patel, VV Dukhande

Cancers 16 (15), 2713

Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells

A Saraswat, K Patel

Experimental Cell Research 438 (1), 114033

Development and in-depth characterization of BRAFi-resistant melanoma cell lines in vitro and in vivo

H Patel, V Raje, P Maczko, K Patel

International Journal of Pharmaceutics 655, 123941

Application of 3D printing technology for the development of dose adjustable geriatric and pediatric formulation of celecoxib

R Hegazy, D Rathod, A Saraswat, R Vartak, A Muth, K Patel

Lenvatinib-valproic acid self nanoemulsifying preconcentrate for the treatment of liver cancer

RD Patel, AS Patel, HJ Patel, S Sarvepalli, K Patel

Journal of Drug Delivery Science and Technology 91, 105276

Development of rapidly soluble mebendazole nanosuspension for colorectal cancer

H Mamidi, S Palekar, H Patel, PK Nukala, K Patel

Drug Discovery Today 28 (12), 103806

Formulation strategies for the development of high drug-loaded amorphous solid dispersions

A Saraswat, R Vartak, R Hegazy, Y Fu, TJR Rao, B Billack, K Patel

Biomedicine & Pharmacotherapy 168, 115754

Oral lipid nanocomplex of BRD4 PROteolysis TArgeting Chimera and vemurafenib for drug-resistant malignant melanoma

R Vartak, B Deore, CA Sanhueza, K Patel

International Journal of Biological Macromolecules 252, 126413

Cetuximab-based PROteolysis targeting chimera for effectual downregulation of NSCLC with varied EGFR mutations

A Saraswat, R Vartak, M Patki, K Patel

Cannabis and Cannabinoid Research 8 (6), 1008-1018

Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir

A Saraswat, K Patel

Nanomedicine 18 (26), 1921-1940

Delineating effect of headgroup and preparation method on transfection versus toxicity of DNA-loaded lipid nanocarriers

Vartak, S Menon, M Patki, X Liang, B Billack, K Patel

Nanomedicines for the Prevention and Treatment of Infectious Diseases, 125-147

Nanomedicine for the Treatment of Vaginal Candidiasis

S Banella, A Saraswat, A Patel, ATM Serajuddin, P Colombo, K Patel, G Colombo

International Journal of Molecular Sciences 24 (21), 15725

In Vitro Assessment of Cisplatin/Hyaluronan Complex for Loco-Regional Chemotherapy

T Richards, JC Perron, K Patel, J Wurpel, SE Reznik, F Schanne

Research Square, rs. 3. rs-3399248

Therapeutic Intervention of Neuroinflammatory Alzheimer Disease Model by Inhibition of Classical Complement Pathway with the Use of Anti-C1r Loaded Exosomes

Y Guo, H Patel, A Saraswat, KV Mateti, K Patel, E Squillante

Journal of Drug Delivery Science and Technology 88, 104852

Screening and optimization of supercritical fluid process for the preparation of albendazole solid dispersion

AK Pandya, LK Vora, C Umeyor, D Surve, A Patel, S Biswas, K Patel, VB Patravale

Advanced Drug Delivery Reviews 200, 115003

Polymeric in situ forming depots for long-acting drug delivery systems

X Liang, S Menon, R Vartak, R Gaida, E Wojaczyńska, K Patel, B Billack

Nanomedicine 18 (18), 1195-1206

Nanoformulation of a novel potent ebselen analog for treatment of vulvovaginal candidiasis

R Hegazy, A Saraswat, R Vartak, K Patel

BRITISH JOURNAL OF PHARMACOLOGY 180, 432-433

Lenvatinib-Valproic Acid Self Nanoemulsifying Preconcentrate for the treatment of Hepatocellular Carcinoma

DK Sahel, LK Vora, A Saraswat, S Sharma, J Monpara, AA D'Souza, D Mishra, KP Tryphena, S Kawakita, S Khan, M Azhar, DK Khatri, K Patel, RRS Thakur

Advanced Science 10 (19), 2207512

CRISPR/Cas9 genome editing for tissue‐specific in vivo targeting: nanomaterials and translational perspective

H Patel, S Palekar, A Patel, K Patel

International Journal of Pharmaceutics 641, 123056

Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer

S Palekar, HK Mamidi, Y Guo, R Vartak, K Patel

International Journal of Pharmaceutics 640, 122989

Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions

A Saraswat, K Patel

Delineating effect of cationic head group and preparation method on transfection versus toxicity of lipid-based nanoparticles for gene delivery

S Daware, V Raje, A Patel, K Patel

Molecular Pharmaceutics 20 (5), 2556-2567

Investigating Key Molecular Descriptors Affecting Particle Size: A Predictive Exemplary Approach for Self-Emulsifying System

T Richards, H Patel, K Patel, F Schanne

Pharmaceuticals 16 (3), 421

Endogenous lipid carriers—bench-to-bedside roadblocks in production and drug loading of exosomes

A Das, R Vartak, MA Islam, S Kumar, J Shao, K Patel

Pharmaceutics 15 (2), 353

Arginine-coated nanoglobules for the nasal delivery of insulin

P Gawali, A Saraswat, S Bhide, S Gupta, K Patel

Nanomedicine 18 (2), 169-190

Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a ‘golden gate’for nanomedicine in preclinical studies?

A Patel, A Saraswat, H Patel, ZS Chen, K Patel

Cancers 15 (1), 182

Palmitoyl carnitine-anchored nanoliposomes for neovasculature-specific delivery of gemcitabine elaidate to treat pancreatic cancer

AL Saraswat, R Vartak, R Hegazy, A Patel, K Patel

Drug Discovery Today 28 (1), 103387

Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs)

R Vartak, J Jablonski, B Deore, S Mediouni, CA Sanhueza, ST Valente, K Patel

International Journal of Biological Macromolecules 221, 416-425

Bictegravir nanomicelles and anionic pullulan loaded vaginal film: Dual mechanistic pre-exposure prophylaxis (PrEP) for HIV

R Vartak, A Saraswat, Y Yang, ZS Chen, K Patel

Pharmaceutical Research 39 (11), 2745-2759

Susceptibility of lung carcinoma cells to nanostructured lipid carrier of ARV-825, a BRD4 degrading proteolysis targeting chimera

S Daware, M Patki, A Saraswat, S Palekar, K Patel

International Journal of Pharmaceutics 626, 122163

Development of a safe pediatric liquisolid self-nanoemulsifying system of triclabendazole for the treatment of fascioliasis

V Raje, S Palekar, S Banella, K Patel

Pharmaceutics 14 (10), 2192

Tunable drug release from fused deposition modelling (FDM) 3D-printed tablets fabricated using a novel extrudable polymer

RS Kalhapure, S Palekar, K Patel, J Monpara

Expert opinion on drug delivery 19 (10), 1303-1316

Nanocrystals for controlled delivery: state of the art and approved drug products

A Mir, RV Vartak, K Patel, SM Yellon, SE Reznik

Pharmaceutics 14 (10), 2019

Vaginal Nanoformulations for the Management of Preterm Birth

S Palekar, PK Nukala, K Patel

International Journal of Pharmaceutics 621, 121804

Aversion liquid-filled drug releasing capsule (3D-RECAL): A novel technology for the development of immediate release abuse deterrent formulations using a fused deposition modelling (FDM) 3D printer

Y Fu, AL Saraswat, J Monpara, K Patel

Drug Discovery Today 27 (4), 1132-1141

Stromal disruption facilitating invasion of a ‘nano-arsenal’into the solid tumor

V Raje, S Palekar, S Banella, K Patel

s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affil-iations.

Tunable drug release from fused deposition modelling (FDM) 3D-printed tablets fabricated using a novel extrudable polymer. Pharmaceutics. 2022; 14: 2192. MDPI

Y Fu, A Saraswat, R Vartak, M Patki, K Patel

Multifunctional Nanocarriers, 79-102

Liposomal formulation: Opportunities, challenges, and industrial applicability

A Saraswat, HP Vemana, VV Dukhande, K Patel

Heliyon 8 (1)

Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy

K Giusto, M Patki, J Koya, CR Ashby Jr, S Munnangi, K Patel, SE Reznik

Nanomedicine 14 (21), 2835-2851

A vaginal nanoformulation of a SphK inhibitor attenuates lipopolysaccharide-induced preterm birth in mice

PK Nukala, S Palekar, M Patki, Y Fu, K Patel

International journal of pharmaceutics 569, 118629

Multi-dose oral abuse deterrent formulation of loperamide using hot melt extrusion

Y Fu, D Rathod, EM Abo-Ali, VV Dukhande, K Patel

Pharmaceutics 11 (10), 504

EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma

D Rathod, Y Fu, K Patel

European Journal of Pharmaceutical Sciences 138, 105039

BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation

T Gandhi, M Patki, J Kong, J Koya, S Yoganathan, S Reznik, K Patel

Molecular Pharmaceutics 16 (10), 4405-4415

Development of an arginine anchored nanoglobule with retrograde trafficking inhibitor (Retro-2) for the treatment of an enterohemorrhagic Escherichia coli outbreak

A Bagde, K Patel, S Kutlehria, N Chowdhury, M Singh

Drug delivery and translational research 9, 816-827

Formulation of topical ibuprofen solid lipid nanoparticle (SLN) gel using hot melt extrusion technique (HME) and determining its anti-inflammatory strength

A Bagde, K Patel, A Mondal, S Kutlehria, N Chowdhury, A Gebeyehu, N Patel, N Kumar, M Singh

AAPS PharmSciTech 20, 1-12

Combination of UVB absorbing titanium dioxide and quercetin nanogel for skin cancer chemoprevention

M Patki, K Giusto, S Gorasiya, SE Reznik, K Patel

Pharmaceutics 11 (7), 335

17-α hydroxyprogesterone nanoemulsifying preconcentrate-loaded vaginal tablet: A novel non-invasive approach for the prevention of preterm birth

K Patel, R Doddapaneni, M Patki, V Sekar, A Bagde, M Singh

AAPS PharmSciTech 20, 1-11

Erlotinib-valproic acid liquisolid formulation: evaluating oral bioavailability and cytotoxicity in erlotinib-resistant non-small cell lung cancer cells

M Sachdeva, K Patel, A Rishi

US Patent 10,220,025

Self-emulsifying formulation of CARP-1 functional mimetics

M Patki, K Patel

Drug development and industrial pharmacy 45 (3), 405-414

Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient

S Palekar, PK Nukala, SM Mishra, T Kipping, K Patel

International journal of pharmaceutics 556, 106-116

Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen

PK Nukala, S Palekar, N Solanki, Y Fu, M Patki, AA Shohatee, L Trombetta, K Patel

Journal of 3D printing in medicine 3 (1), 23-37

Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms

PK Nukala, S Palekar, M Patki, K Patel

Aaps Pharmscitech 20, 1-12

Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction

M Sachdeva, K Patel, A Rishi

US Patent 10,172,838

Self-emulsifying formulation of CARP-1 functional mimetics

N Gudadhe, JD Thanki, KK Patel, DD Patel, MK Arvadia

Indian Journal of Fertilisers 14 (11), 1-7

Integrated nitrogen management package for sustainable maizeyield and soil health with and without vermiwash

N Chowdhury, I Vhora, K Patel, A Bagde, S Kutlehria, M Singh

AAPS PharmSciTech 19, 3287-3297

Development of hot melt extruded solid dispersion of tamoxifen citrate and resveratrol for synergistic effects on breast cancer cells

S Kutlehria, I Vhora, A Bagde, N Chowdhury, G Behl, K Patel, M Singh

Pharmaceutical research 35, 1-12

Tacrolimus loaded PEG-cholecalciferol based micelles for treatment of ocular inflammation

S Kutlehria, G Behl, K Patel, R Doddapaneni, I Vhora, N Chowdhury, A Bagde, M Singh

AAPS PharmSciTech 19 (2), 792-802

Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer

M Sachdeva, K Patel

US Patent 9,867,827

Methods and formulations for topical treatment of psoriasis

D Chobisa, K Patel, J Monpara, M Patel, P Vavia

International journal of pharmaceutics 535 (1-2), 360-370

Development and characterization of an organic solvent free, proliposomal formulation of Busulfan using quality by design approach

R Doddapaneni, K Patel, N Chowdhury, M Singh

Scientific Reports 7 (1), 15824

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer

N Chowdhury, I Vhora, K Patel, R Doddapaneni, A Mondal, M Singh

Pharmaceutical research 34, 2371-2384

Liposomes co-loaded with 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) shRNA plasmid and docetaxel for the treatment of non-small cell lung cancer

MS Sachdeva, K Patel, C Godugu

US Patent App. 15/248,452

Composition for improving bioavailbility and efficacy of taxane

CHA Boakye, K Patel, R Doddapaneni, A Bagde, S Marepally, M Singh

Journal of Controlled Release 246, 120-132

Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment

CHA Boakye, K Patel, AR Patel, HAM Faria, V Zucolotto, S Safe, M Singh

Drug Delivery and Translational Research 6, 526-539

Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation

CHA Boakye, K Patel, AR Patel, HAM Faria, V Zucolotto, S Safe, M Singh

Drug Delivery and Translational Research 6, 526-539

CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers

R Doddapaneni, K Patel, N Chowdhury, M Singh

Experimental cell research 346 (1), 65-73

Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer

R Doddapaneni, K Patel, N Chowdhury, M Sachdeva

Cancer Research 76 (14_Supplement), 2086-2086

Noscapine chemosensitization enhances docetaxel anticancer activity and tumor stroma disruption against triple negative breast cancer

CHA Boakye, K Patel, R Doddapaneni, A Bagde, G Behl, N Chowdhury, S Safe, M Singh

Colloids and Surfaces B: Biointerfaces 143, 156-167

Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention

K Patel, R Doddapaneni, V Sekar, N Chowdhury, M Singh

Molecular pharmaceutics 13 (6), 2049-2058

ombination approach of YSA peptide anchored docetaxel stealth liposomes with oral antifibrotic agent for the treatment of lung cancer

K Patel, R Doddapaneni, N Chowdhury, CHA Boakye, G Behl, M Singh

Nanomedicine 11 (11), 1377-1392

Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer

R Doddapaneni, K Patel, IH Owaid, M Singh

Drug delivery 23 (4), 1232-1241

Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer

A Lacey, E Hedrick, X Li, K Patel, R Doddapaneni, M Singh, S Safe

Oncotarget 7 (21), 31257

Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS)

K Patel, N Chowdhury, R Doddapaneni, CHA Boakye, C Godugu, M Singh

Journal of pharmaceutical sciences 104 (12), 4417-4426

Piperlongumine for enhancing oral bioavailability and cytotoxicity of docetaxel in triple-negative breast cancer

R Doddapaneni, K Patel, M Singh

Cancer Research 75 (15_Supplement), 2619-2619

Synergistic anticancer effect of Noscapine and Camptothecin is mediated through apoptosis and cell cycle arrest in A549 lung cancer

CHA Boakye, K Patel, M Singh

International journal of pharmaceutics 489 (1-2), 106-116

Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers

L Vora, M Tyagi, K Patel, S Gupta, P Vavia

Journal of nanoparticle research 16, 1-13

Self-assembled nanocomplexes of anionic pullulan and polyallylamine for DNA and pH-sensitive intracellular drug delivery

K Patel, A Patil, M Mehta, V Gota, P Vavia

International journal of pharmaceutics 472 (1-2), 214-223

Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity

K Patel, M Tyagi, J Monpara, L Vora, S Gupta, P Vavia

Journal of nanoparticle research 16, 1-10

Arginoplexes: an arginine-anchored nanoliposomal carrier for gene delivery

K Patel, V Sarma, P Vavia

DARU Journal of Pharmaceutical Sciences 21, 1-11

Design and evaluation of lumefantrine–oleic acid self nanoemulsifying ionic complex for enhanced dissolution

K Patel, A Patil, M Mehta, V Gota, P Vavia

Journal of biomedical nanotechnology 9 (12), 1996-2006

Medium chain triglyceride (MCT) rich, paclitaxel loaded self nanoemulsifying preconcentrate (PSNP): a safe and efficacious alternative to Taxol®

S Chavan, K Patel, D Shelar, P Vavia

American Journal of pharmtech research 3 (1), 557-569

Preparation of Oxcarbazepine Solid Dispersion by Hot Melt Extrusion for Enhanced Dissolution: Downstream Processing to Tablets

TD Nandedkar, P Sagvekar, B Thakur, R Navlakhe, S Chitnis, SD Mahale, S D’Souza, KD Patel, PR Vavia

NISCAIR-CSIR, India

Polymeric nanoparticle formulation of Octapeptide (NP-OP): In vitro release and in vivo effect in common marmosets, Callithrix jacchus Linn.

K Patel, S Padhye, M Nagarsenker

Aaps Pharmscitech 13, 125-133

Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design

PATEL RESEARCH LAB

Our Publications